IMV

-$0.01 (-0.57%) As of 7:20 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IMV and other ETFs, options, and stocks.

About IMV

IMV, Inc. is a clinical-stage biopharmaceutical company that engages in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. The company leverages its delivery platform (DPX) that programs immune cells directly within the human body to produce robust and sustained target killing capabilities.

CEO
Frederic Ors
Employees
—
Headquarters
Dartmouth, Nova Scotia
Founded
2007

IMV Key Statistics

Market Cap
157.40M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
10.15M
High Today
$1.80
Low Today
$1.72
Open Price
$1.75
Volume
729.19K
52 Week High
$5.73
52 Week Low
$1.31

IMV Earnings

-$0.19
-$0.13
-$0.06
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure